it is concluded that circulating immune complexes between surfactant and antibodies to surfactant are probably found in most neonates with respiratory distress syndrome , that they do not produce pulmonary damage detectable by clinical and serologic means , and that treatment of neonatal rds with human surfactant similarly does not produce lung injury as determined with these techniques .
C0003313
circulating immune complexes
C0003241
antibodies